[{"Assets_0_Q2_USD":306017000.0,"CommonStockSharesOutstanding_0_Q2_shares":24028504.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-21356000.0,"NetIncomeLoss_1_Q2_USD":-13618000.0,"NetIncomeLoss_2_Q2_USD":-28704000.0,"StockholdersEquity_0_Q2_USD":284979000.0,"Ticker":"ANAB","CIK":"1370053","name":"ANAPTYSBIO INC","OfficialName":"AnaptysBio Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"617648593.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]